# Dermal Blood Flow Response to Escalating Doses of Histamine, Administered by a Skin Prick

> **NCT04399213** · NA · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 13 (actual)

## Conditions studied

- Pruritus

## Interventions

- **PROCEDURE:** 50 µg Histamine
- **PROCEDURE:** 15 µg Histamine
- **PROCEDURE:** 5 µg Histamine
- **PROCEDURE:** Placebo (saline)

## Key facts

- **NCT ID:** NCT04399213
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2019-02-19
- **Final completion:** 2019-02-19
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399213, "Dermal Blood Flow Response to Escalating Doses of Histamine, Administered by a Skin Prick". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04399213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*